PERIPHERAL BLOOD DNA METHYLATION PROFILES IDENTIFY IDH1/2 MUTATION STATUS IN ADULTS WITH DIFFUSE GLIOMA

被引：0
|
作者：
Kloetgen, Andreas [1 ]
Serrano, Jonathan [1 ]
Patel, Seema [1 ]
Bowman, Christopher [2 ]
Shen, Guomiao [1 ]
Zagzag, David [1 ]
Karajannis, Matthias [3 ]
Golfinos, John [1 ]
Placantonakis, Dimitris [1 ]
Tsirigos, Aristotelis [1 ]
Chi, Andrew S. [1 ]
Snuderl, Matija [1 ]
机构：
[1] NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GENE-02
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [31] IDH1/2 mutation status combined with Ki-67 labeling index defines distinct prognostic groups in glioma
    Zeng, Ailiang
    Hu, Qi
    Liu, Yanwei
    Wang, Zheng
    Cui, Xiaoming
    Li, Rui
    Yan, Wei
    You, Yongping
    ONCOTARGET, 2015, 6 (30) : 30232 - 30238
  • [32] Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients
    Liu, Xipeng
    Liu, Ming
    Cao, Bing
    Qiao, Jianxin
    Zhang, Xiufeng
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (03) : 843 - 847
  • [33] Absence of IDH1 R132H Mutation Predicts Rapid Progression of Non-Enhancing Diffuse Glioma in Older Adults.
    Olar, A.
    Raghunathan, A.
    Albarracin, C. T.
    Aldape, K. D.
    Cahill, D. P.
    Powell, S. Z.
    Goodman, C.
    Fuller, G. N.
    MODERN PATHOLOGY, 2011, 24 : 383A - 384A
  • [34] Construction of ceRNA networks with different types of IDH1 mutation status in low-grade glioma patients
    Wang, Wen-Jie
    Lu, Yu-Jie
    Li, Ying
    Tang, Jie-Qing
    Wang, Han
    Song, Wei
    Wang, Jing-Jing
    Huang, Yue-Qing
    Wang, Ying
    Lian, Lian
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (05)
  • [35] Identification of Retinol Binding Protein 1 (RBP1) Methylation as a Marker of IDH1 and IDH2 Mutation in Gliomas
    Chou, Arthur Po-Fei
    Chowdhury, Reshmi
    Li, Sichen
    Chen, Weidong
    Kim, Andrew
    Selfridge, Julia
    Piccioni, David
    Chang, Stephen
    Lalezari, Shadi
    Lin, Jeffrey
    Prins, Robert
    Mischel, Paul
    Yong, William
    Cloughesy, Timothy
    Nelson, Stanley
    Liau, Linda
    Lai, Albert
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : A425 - A426
  • [36] Distinctive clinicopathological features and KRAS and IDH1/2 mutation status of cholangiolocellular carcinoma
    Kusano, Hironori
    Naito, Yoshiki
    Mihara, Yutaro
    Kondo, Reiichiro
    Ogasawara, Sachiko
    Akiba, Jun
    Nakashima, Osamu
    Yano, Hirohisa
    HEPATOLOGY RESEARCH, 2020, 50 (01) : 84 - 91
  • [37] ANALYSIS OF THE BIOCHEMICAL PROFILE OF LOW GRADE GLIOMA WITH DIFFERENT IDH1 MUTATION STATUS USING VIBRATIONAL SPECTROSCOPY
    Uckermann, Ortrud
    Juratli, Tareq
    Conde, Marina
    Galli, Roberta
    Krex, Dietmar
    Geiger, Kathrin
    Schackert, Gabriele
    Temme, Achim
    Steiner, Gerald
    Kirsch, Matthias
    NEURO-ONCOLOGY, 2014, 16
  • [38] Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection
    Wefel, Jeffrey S.
    Noll, Kyle R.
    Rao, Ganesh
    Cahill, Daniel P.
    NEURO-ONCOLOGY, 2016, 18 (12) : 1656 - 1663
  • [39] Mutation of IDH1/2 is strongly associated with MGMT methylation in adult astrocytic and oligodendroglial tumors
    Mulholland, Shani A.
    Malley, Deborah S.
    Hamoudi, Rifat
    Kocialkowski, Sylvia
    Pearson, Danita
    Collins, V. Peter
    Ichimura, Koichi
    CANCER RESEARCH, 2011, 71
  • [40] O6-methyl-guanine-DNA methyltransferase methylation and IDH1/2 mutation in small cell lung cancer
    Lu, Hongyang
    Qin, Jing
    Xu, Haimiao
    Han, Na
    Xie, Fajun
    Mao, Weimin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (01) : 398 - 402
12345